These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26439715)

  • 1. Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells.
    Burridge PW; Holmström A; Wu JC
    Curr Protoc Hum Genet; 2015 Oct; 87():21.3.1-21.3.15. PubMed ID: 26439715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes.
    Lin Y; Linask KL; Mallon B; Johnson K; Klein M; Beers J; Xie W; Du Y; Liu C; Lai Y; Zou J; Haigney M; Yang H; Rao M; Chen G
    Stem Cells Transl Med; 2017 Feb; 6(2):527-538. PubMed ID: 28191759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
    van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
    Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation.
    Sharma A; Li G; Rajarajan K; Hamaguchi R; Burridge PW; Wu SM
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells in Fully Chemically Defined Conditions.
    Lin Y; Zou J
    STAR Protoc; 2020 Jun; 1(1):. PubMed ID: 32734277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High content screening for modulators of cardiac differentiation in human pluripotent stem cells.
    Spiering S; Davidovics H; Bushway PJ; Mercola M; Willems E
    Methods Mol Biol; 2015; 1263():43-61. PubMed ID: 25618335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient differentiation of cardiomyocytes from human pluripotent stem cells with growth factors.
    Jha R; Xu RH; Xu C
    Methods Mol Biol; 2015; 1299():115-31. PubMed ID: 25836579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
    Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically Defined Neural Conversion of Human Pluripotent Stem Cells.
    Chen Y; Tristan CA; Mallanna SK; Ormanoglu P; Titus S; Simeonov A; Singeç I
    Methods Mol Biol; 2019; 1919():59-72. PubMed ID: 30656621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
    Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
    Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Priming of Human Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Accelerates Cardiomyocyte Maturation.
    Biermann M; Cai W; Lang D; Hermsen J; Profio L; Zhou Y; Czirok A; Isai DG; Napiwocki BN; Rodriguez AM; Brown ME; Woon MT; Shao A; Han T; Park D; Hacker TA; Crone WC; Burlingham WJ; Glukhov AV; Ge Y; Kamp TJ
    Stem Cells; 2019 Jul; 37(7):910-923. PubMed ID: 31087611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.
    Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET
    PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional improvement and maturation of human cardiomyocytes derived from human pluripotent stem cells by barbaloin preconditioning.
    Yang H; Zhong W; Hamidi MR; Zhou G; Liu C
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):1041-1048. PubMed ID: 31518384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Protocol for Cardiac Differentiation and Maturation of Pluripotent Stem Cells.
    Jebeniani I; Ding S; Pucéat M
    Methods Mol Biol; 2019; 1994():71-77. PubMed ID: 31124105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells.
    Zanella F; Sheikh F
    Methods Mol Biol; 2016; 1353():147-62. PubMed ID: 25520292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Burridge PW; Diecke S; Matsa E; Sharma A; Wu H; Wu JC
    Methods Mol Biol; 2016; 1353():119-30. PubMed ID: 25690476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling.
    Kadari A; Mekala S; Wagner N; Malan D; Köth J; Doll K; Stappert L; Eckert D; Peitz M; Matthes J; Sasse P; Herzig S; Brüstle O; Ergün S; Edenhofer F
    Stem Cell Rev Rep; 2015 Aug; 11(4):560-9. PubMed ID: 25392050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.